Comparative Effectiveness Researchers Look Beyond Randomized Trials
This article was originally published in The Gray Sheet
Executive Summary
Researchers awaiting guidance from the Administration on how it will allocate $1.1 billion in stimulus funds for comparative effectiveness research are exploring ways to include alternatives to randomized clinical trials in gathering evidence to inform health care decisions